|
ZNF470 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.734790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.402400E-01 |
| Normal-vs-Stage2 |
1.665840E-01 |
| Normal-vs-Stage3 |
1.117710E-02 |
| Normal-vs-Stage4 |
6.839200E-04 |
| Stage1-vs-Stage2 |
3.762300E-02 |
| Stage1-vs-Stage3 |
5.171900E-04 |
| Stage1-vs-Stage4 |
9.73749999999551E-05 |
| Stage2-vs-Stage3 |
5.924600E-01 |
| Stage2-vs-Stage4 |
2.534800E-01 |
| Stage3-vs-Stage4 |
5.210600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.607800E-01 |
| Normal-vs-AfricanAmerican |
8.765600E-01 |
| Normal-vs-Asian |
9.119800E-01 |
| Caucasian-vs-AfricanAmerican |
6.081600E-01 |
| Caucasian-vs-Asian |
9.041000E-01 |
| AfricanAmerican-vs-Asian |
9.363000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.373760E-01 |
| Normal-vs-Female |
5.608200E-01 |
| Male-vs-Female |
5.148200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.460100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.974600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.239800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.216300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.847630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.131400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.713000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.768400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.224800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.581200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.997300E-03 |
| Normal-vs-Grade 2 |
5.412100E-02 |
| Normal-vs-Grade 3 |
7.318000E-03 |
| Normal-vs-Grade 4 |
1.05020000473743E-08 |
| Grade 1-vs-Grade 2 |
6.232500E-02 |
| Grade 1-vs-Grade 3 |
5.000100E-04 |
| Grade 1-vs-Grade 4 |
4.31509999954116E-08 |
| Grade 2-vs-Grade 3 |
9.54069999999918E-05 |
| Grade 2-vs-Grade 4 |
7.71339658811598E-11 |
| Grade 3-vs-Grade 4 |
7.809000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.382700E-03 |
| Normal-vs-ccB subtype |
2.70069999996903E-06 |
| ccA subtype-vs-ccB subtype |
2.05540029440954E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.439600E-02 |
| Normal-vs-N1 |
6.995200E-04 |
| N0-vs-N1 |
4.897400E-03 |
|
|
